BUZZ-AstraZeneca: dives off 1-yr highs after update
** AstraZeneca (NYSE: AZN - news) top of the FTSE 100 fallers' list as some analysts query the sustainability of its EPS beat
** They flag that earnings were enhanced by the partial sell-off of a number of drugs
** Stock called up 1-2 pct by brokers in the pre-market; posts core EPS $1.08 (down 7 pct), above consensus $1.07, but shares dived off 1-yr highs hit recently & drop nearly 3 pct
** Deutsche Bank (Xetra: 514000 - news) reckons further question marks will be raised over the quality of earnings from the base business, though expects consensus EPS forecasts & pipeline-based investment case to be unchanged; repeats "hold" rating (RM (LSE: RM.L - news) : tricia.wright1.thomsonreuters.com@reuters.net)